SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OCGT again
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dave Baker who wrote (61)10/4/1996 9:43:00 AM
From: Jack Ucci   of 283
 
Dave & all,

1. The stock movement has clearly been a 'deal' type play. Each rumor of a soon-to-be realized deal sends ocgt upward, with the subsequent selloff at the announcement.

2. While my broker turns a deaf ear to mention of possible earnings as irrelevant, it also seems clear that what is missing from the ocgt story is some financial results. Who knows what revenues are generated by these deals? Is there some unannounced cost to achieving these deals, such as a rake off to the marketer?

When this company shows $-numbers fleshing out the value of these deals, then ocgt should fly. Before then, who knows the value of ocgt?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News